CATCH-UP: NCI ETCTN Pittsburgh Cancer Consortium (PCC)

摘要 提交此申请是为了请求将附属组织添加到早期 治疗学临床试验网络（ETCTN）UM 1领导学术组织。 加州大学欧文分校（UCI）的Chao家庭综合癌症中心（CFCCC） 被证明是一个表现良好的网站，在创建访问有针对性的癌症治疗不足 人群（CATCH-UP）计划，共招募了34例患者，其中近一半（48%）来自不同的 患者人群（例如拉丁裔、亚裔和服务不足地区）。随着CFCCC成功参与 CATCH-UP，CFCCC将被整合到匹兹堡癌症联盟（PCC），为他们提供访问 所有ETCTN试验的患者。 PCC将通过提供监管支持、数据协调和不良反应报告， 由UCI研究人员领导的研究的事件和结果。此外，PCC将通过以下方式支持CFCCC： 在ETCTN试验中发展概念和领导力。相反，CFCCC将利用他们的经验， 在CATCH-UP计划中取得成功，在PCC中部署服务不足的患者累积的最佳实践。

ABSTRACT This application is being submitted to request the addition of an Affiliated Organization(s) to the Early Therapeutics Clinical Trial Network (ETCTN) UM1 Lead Academic Organization. The Chao Family Comprehensive Cancer Center (CFCCC) of the University of California, Irvine (UCI) has demonstrated to be a well performing site in the Create Access to Targeted Cancer Therapy for Underserved Populations (CATCH-UP) program, enrolling a total of 34 patients with nearly half (48%) coming from diverse patient populations (e.g. Latino, Asian and underserved areas). With the success of CFCCC’s participation in CATCH-UP, CFCCC will be integrated into the Pittsburgh Cancer Consortium (PCC), providing access for their patients to all ETCTN trials. The PCC will integrate CFCCC by providing regulatory support, data coordination and reporting of adverse events and outcomes on the studies led by UCI investigators. In addition, the PCC will support CFCCC through development of concepts and leadership in ETCTN trials. Conversely, CFCCC will use their experience and success in the CATCH-UP program to deploy best practices in underserved patient accrual in the PCC.